The FDA announced it will begin examining a potential link between a popular allergy drug and suicide. The review was prompted by three-to-four reports the FDA received about patients using the drug committing suicide. The drugs listed side effects already include tremors, anxiousness, depression and suicidal thinking and behavior. In response to the announcement, the company has stated it will list reports of suicide on the drug’s label. If a link is found by the FDA, consumers must once again wonder how truthful drug companies are in reporting clinical research relating to the side effects of mass-market drugs.
For the full article, click here: